| Risk to all or none?: A comparative analysis of controversies in the health risk assessment of Bisphenol A A Beronius, C Rudén, H Håkansson, A Hanberg Reproductive Toxicology 29 (2), 132-146, 2010 | 199 | 2010 |
| A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals LN Vandenberg, M Ågerstrand, A Beronius, C Beausoleil, Å Bergman, ... Environmental health 15, 1-19, 2016 | 119 | 2016 |
| Overview on legislation and scientific approaches for risk assessment of combined exposure to multiple chemicals: the potential EuroMix contribution S Rotter, A Beronius, AR Boobis, A Hanberg, J Van Klaveren, M Luijten, ... Critical reviews in toxicology 48 (9), 796-814, 2018 | 91 | 2018 |
| Facilitating the use of non‐standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting A Beronius, L Molander, C Rudén, A Hanberg Journal of Applied Toxicology 34 (6), 607-617, 2014 | 60 | 2014 |
| The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A, implications for toxicity testing A Beronius, N Johansson, C Rudén, A Hanberg Toxicology 311 (1-2), 13-26, 2013 | 59 | 2013 |
| Recommendations for the conduct of systematic reviews in toxicology and environmental health research (COSTER) P Whaley, E Aiassa, C Beausoleil, A Beronius, G Bilotta, A Boobis, ... Environment international 143, 105926, 2020 | 55 | 2020 |
| Weight of evidence evaluation and systematic review in EU chemical risk assessment: Foundation is laid but guidance is needed M Ågerstrand, A Beronius Environment International 92, 590-596, 2016 | 46 | 2016 |
| Review of non‐monotonic dose‐responses of substances for human risk assessment C Beausoleil, A Beronius, L Bodin, BGH Bokkers, PE Boon, M Burger, ... EFSA Supporting Publications 13 (5), 1027E, 2016 | 41 | 2016 |
| Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals A Beronius, LN Vandenberg Reviews in Endocrine and Metabolic Disorders 16, 273-287, 2015 | 39 | 2015 |
| Science in Risk Assessment and Policy (SciRAP): An Online Resource for Evaluating and Reporting In Vivo (Eco)Toxicity Studies L Molander, M Ågerstrand, A Beronius, A Hanberg, C Rudén Human and Ecological Risk Assessment: An International Journal 21 (3), 753-762, 2015 | 39 | 2015 |
| Methodology for health risk assessment of combined exposures to multiple chemicals A Beronius, J Zilliacus, A Hanberg, M Luijten, H van der Voet, ... Food and Chemical Toxicology 143, 111520, 2020 | 38 | 2020 |
| The MCRA toolbox of models and data to support chemical mixture risk assessment H van Der Voet, JW Kruisselbrink, WJ de Boer, MS van Lenthe, ... Food and Chemical Toxicology 138, 111185, 2020 | 28 | 2020 |
| Testing and refining the Science in Risk Assessment and Policy (SciRAP) web‐based platform for evaluating the reliability and relevance of in vivo toxicity studies A Beronius, L Molander, J Zilliacus, C Rudén, A Hanberg Journal of Applied Toxicology 38 (12), 1460-1470, 2018 | 28 | 2018 |
| Bridging the gap between academic research and regulatory health risk assessment of endocrine disrupting chemicals A Beronius, A Hanberg, J Zilliacus, C Rudén Current opinion in pharmacology 19, 99-104, 2014 | 27 | 2014 |
| Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union A Beronius, C Rudén, A Hanberg, H Håkansson Regulatory toxicology and pharmacology 55 (2), 111-122, 2009 | 22 | 2009 |
| Evaluating the evidence for non-monotonic dose-response relationships: A systematic literature review and (re-) analysis of in vivo toxicity data in the area of food safety C Varret, A Beronius, L Bodin, BGH Bokkers, PE Boon, M Burger, ... Toxicology and Applied Pharmacology 339, 10-23, 2018 | 21 | 2018 |
| Transparency of chemical risk assessment data under REACH E Ingre-Khans, M Ågerstrand, A Beronius, C Rudén Environmental Science: Processes & Impacts 18 (12), 1508-1518, 2016 | 21 | 2016 |
| Factors modulating COVID-19: a mechanistic understanding based on the adverse outcome pathway framework LA Clerbaux, MC Albertini, N Amigó, A Beronius, GFG Bezemer, ... Journal of Clinical Medicine 11 (15), 4464, 2022 | 18 | 2022 |
| A call for action: Improve reporting of research studies to increase the scientific basis for regulatory decision‐making M Ågerstrand, S Christiansen, A Hanberg, C Rudén, L Andersson, ... Journal of Applied Toxicology 38 (5), 783-785, 2018 | 17 | 2018 |
| Reliability and relevance evaluations of REACH data E Ingre-Khans, M Ågerstrand, A Beronius, C Rudén Toxicology Research 8 (1), 46-56, 2019 | 16 | 2019 |
